GPRC5D and plasmacytoma: Specifically, a biallelic loss of the G-protein-coupled receptor class 5 member D (GPRC5D) gene, due to local chromosomal deletion, was identified in a patient with recurrent plasmacytoma post GPRC5D-targeted CAR-T therapy [4].